Rok Seon Choung1, Ivo C Ditah1, Ashley M Nadeau1, Alberto Rubio-Tapia1, Eric V Marietta1, Tricia L Brantner1, Michael J Camilleri2, S Vincent Rajkumar3, Ola Landgren4, James E Everhart5, Joseph A Murray1. 1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. 2. Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA. 3. Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. 4. Myeloma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. 5. Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Abstract
OBJECTIVES: Racial disparities in the prevalence of celiac disease (CD) and the number of people without CD avoiding gluten (PWAG) in the United States are unknown. We aimed to describe racial differences in the prevalence of CD and PWAG, and evaluate the trends of CD in the noninstitutionalized civilian adult population of the US between 1988 and 2012. METHODS: A population-based cross-sectional study was conducted using data from the National Health and Nutrition Examination Surveys (NHANES) from 1988 to 1994, 1999 to 2004, and 2009 to 2012. Serum samples from the NHANES participants were tested for CD serology, which included IgA tissue transglutaminase (tTG IgA) and, if findings were abnormal, for IgA endomysial antibodies. Information about adherence to a gluten-free diet was obtained by means of an interviewer-administered questionnaire. RESULTS: In NHANES 2009-2012, the adjusted prevalence of CD was significantly higher (P<0.0001) among non-Hispanic whites (1.0%) than among non-Hispanic blacks (0.2%) and Hispanics (0.3%), whereas the adjusted prevalence of PWAG was significantly higher (P=0.01) in blacks (1.2%) as compared with Hispanics (0.5%) and whites (0.7%). The seroprevalence of CD in adults aged 50 years and older increased from 0.17% (95% confidence interval (CI) 0.03-0.33) in 1988-1994 to 0.44% (95% CI 0.24-0.81) in 2009-2012 (P<0.05). CONCLUSIONS: The overall prevalence of CD increased between 1988 and 2012 and is significantly more common in whites. In addition, a higher proportion of individuals maintaining a gluten-free diet in the absence of a diagnosis of CD are blacks.
OBJECTIVES: Racial disparities in the prevalence of celiac disease (CD) and the number of people without CD avoiding gluten (PWAG) in the United States are unknown. We aimed to describe racial differences in the prevalence of CD and PWAG, and evaluate the trends of CD in the noninstitutionalized civilian adult population of the US between 1988 and 2012. METHODS: A population-based cross-sectional study was conducted using data from the National Health and Nutrition Examination Surveys (NHANES) from 1988 to 1994, 1999 to 2004, and 2009 to 2012. Serum samples from the NHANES participants were tested for CD serology, which included IgA tissue transglutaminase (tTG IgA) and, if findings were abnormal, for IgA endomysial antibodies. Information about adherence to a gluten-free diet was obtained by means of an interviewer-administered questionnaire. RESULTS: In NHANES 2009-2012, the adjusted prevalence of CD was significantly higher (P<0.0001) among non-Hispanic whites (1.0%) than among non-Hispanic blacks (0.2%) and Hispanics (0.3%), whereas the adjusted prevalence of PWAG was significantly higher (P=0.01) in blacks (1.2%) as compared with Hispanics (0.5%) and whites (0.7%). The seroprevalence of CD in adults aged 50 years and older increased from 0.17% (95% confidence interval (CI) 0.03-0.33) in 1988-1994 to 0.44% (95% CI 0.24-0.81) in 2009-2012 (P<0.05). CONCLUSIONS: The overall prevalence of CD increased between 1988 and 2012 and is significantly more common in whites. In addition, a higher proportion of individuals maintaining a gluten-free diet in the absence of a diagnosis of CD are blacks.
Authors: A Ivarsson; L A Persson; L Nyström; H Ascher; B Cavell; L Danielsson; A Dannaeus; T Lindberg; B Lindquist; L Stenhammar; O Hernell Journal: Acta Paediatr Date: 2000-02 Impact factor: 2.299
Authors: Jill M Norris; Katherine Barriga; Edward J Hoffenberg; Iman Taki; Dongmei Miao; Joel E Haas; Lisa M Emery; Ronald J Sokol; Henry A Erlich; George S Eisenbarth; Marian Rewers Journal: JAMA Date: 2005-05-18 Impact factor: 56.272
Authors: T P Chorzelski; E H Beutner; J Sulej; H Tchorzewska; S Jablonska; V Kumar; A Kapuscinska Journal: Br J Dermatol Date: 1984-10 Impact factor: 9.302
Authors: Anita Kondrashova; Kirsi Mustalahti; Katri Kaukinen; Hanna Viskari; Vera Volodicheva; Anna-Maija Haapala; Jorma Ilonen; Mikael Knip; Markku Mäki; Heikki Hyöty Journal: Ann Med Date: 2008 Impact factor: 4.709
Authors: Mohammed R Jafri; Charles W Nordstrom; Joseph A Murray; Carol T Van Dyke; Ross A Dierkhising; Alan R Zinsmeister; Lee J Melton Journal: Dig Dis Sci Date: 2007-10-13 Impact factor: 3.199
Authors: Edwin Liu; Hye-Seung Lee; Carin A Aronsson; William A Hagopian; Sibylle Koletzko; Marian J Rewers; George S Eisenbarth; Polly J Bingley; Ezio Bonifacio; Ville Simell; Daniel Agardh Journal: N Engl J Med Date: 2014-07-03 Impact factor: 176.079
Authors: Rok Seon Choung; Shahryar Khaleghi; Amanda K Cartee; Eric V Marietta; Joseph J Larson; Katherine S King; Otto Savolainen; Alastair B Ross; S Vincent Rajkumar; Michael J Camilleri; Alberto Rubio-Tapia; Joseph A Murray Journal: Gastroenterology Date: 2019-09-24 Impact factor: 22.682
Authors: Jacalyn A See; Katri Kaukinen; Govind K Makharia; Peter R Gibson; Joseph A Murray Journal: Nat Rev Gastroenterol Hepatol Date: 2015-09-22 Impact factor: 46.802
Authors: Anna Krigel; Kevin O Turner; Govind K Makharia; Peter H R Green; Robert M Genta; Benjamin Lebwohl Journal: Clin Gastroenterol Hepatol Date: 2016-05-04 Impact factor: 11.382
Authors: Rok Seon Choung; Aynur Unalp-Arida; Constance E Ruhl; Tricia L Brantner; James E Everhart; Joseph A Murray Journal: Mayo Clin Proc Date: 2016-12-05 Impact factor: 7.616
Authors: Haley M Zylberberg; Ryan T Demmer; Joseph A Murray; Peter H R Green; Benjamin Lebwohl Journal: Eur J Gastroenterol Hepatol Date: 2017-09 Impact factor: 2.566